VCYT(Veracyte, Inc.) · 财务报表

VCYT(Veracyte, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$219.51M$296.54M$361.05M$445.76M$517.14M
毛利润—$175.68M$229.68M$298.14M$362.53M
营业利润−$81.90M−$41.08M−$85.80M$16.14M$57.78M
净利润−$75.56M−$36.56M−$74.40M$24.14M$66.35M
经营现金流−$31.62M$7.54M$44.22M$75.10M$136.31M
自由现金流−$37.00M−$1.01M$34.26M$63.81M$126.63M
摊薄每股收益$-1.11$-0.51$-1.02$0.31$0.82

Veracyte, Inc. VCYT